Shop by goal

Popular compounds

GHK-Cu

Retatrutide

Research resources

Certificates of Analysis

Klow: Stacks research guide

In short: Klow is a four-compound research blend - the Glow trio of GHK-Cu, BPC-157 and TB-500 with KPV added, pairing matrix and repair signalling with the alpha-MSH anti-inflammatory fragment. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

Not medical advice. Klow is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

Klow at a glance

Compound type

Research peptide

Research category

Stacks

Also known as

KLOW stack, KLOW blend, KPV + GHK-Cu + BPC-157 + TB-500, four-peptide repair blend

Research-grade purity

>99% HPLC (per component)

Evidence context

Preclinical / research use only

Regulatory status

Not an approved medicine. Supplied as a research compound

Last reviewed

29 July 2026

What to know first

Four research compounds pre-combined in a single vial - one reconstitution instead of four

KPV (10 mg): alpha-MSH C-terminal tripeptide studied for anti-inflammatory signalling

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways

Details and limits sit in the sections below. Research use only.

What Klow is

Klow is a fixed research blend of KPV, GHK-Cu, BPC-157 and TB-500 - 80 mg of total peptide per vial, adding an anti-inflammatory tripeptide to the Glow composition.

One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

Klow is a four-compound research blend - the Glow trio of GHK-Cu, BPC-157 and TB-500 with KPV added, pairing matrix and repair signalling with the alpha-MSH anti-inflammatory fragment.

Research contexts

Peer-reviewed papers discuss Klow in specific lab settings. The points below reflect research questions, not health claims.

Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

Typical study contexts

Component peptides are usually characterised individually first; combination papers are less common.

Four research compounds pre-combined in a single vial - one reconstitution instead of four.

KPV (10 mg): alpha-MSH C-terminal tripeptide studied for anti-inflammatory signalling.

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling.

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways.

Why Stacks research matters

Stack products combine research peptides. Guides note how components are usually studied alone first.

Mechanisms (technical review)

Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

Four research compounds pre-combined in a single vial - one reconstitution instead of four

KPV (10 mg): alpha-MSH C-terminal tripeptide studied for anti-inflammatory signalling

GHK-Cu (50 mg): copper-binding tripeptide studied for matrix remodelling and collagen signalling

BPC-157 (10 mg): pentadecapeptide studied for angiogenic and tissue-repair pathways

TB-500 (10 mg): thymosin beta-4 fragment studied for actin binding and cell migration

Adds an inflammation-signalling arm to the Glow composition without changing the other three

Lab handling & preparation

Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.

Research dosing context: Literature typically discusses Research protocols for the blend follow the component literature rather than a combined schedule. Component studies commonly use daily or alternate-day subcutaneous administration in short cycles No pharmacokinetic study exists for the four compounds administered as a fixed blend - they have distinct half-lives and clearance routes, and combining them does not create a shared profile. KPV in particular is often studied by oral and topical routes in the published literature, which the injectable blend format does not reproduce. Any protocol should be derived from the individual component literature. These figures describe published research and are not a dosing recommendation.

Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.

Purity check: Use the COA reading guide and the published Klow Certificate of Analysis.

Common Questions People Are Asking

What is in the Klow stack?

Each vial contains KPV 10 mg, GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg - 80 mg of total peptide. The ratio is fixed across every vial in the pack. All four components are available individually, and the Glow blend supplies the same three non-KPV components at identical quantities.

What is the difference between Klow and Glow?

KPV. Klow is the Glow composition - GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg - with KPV added at 10 mg, taking the vial from 70 mg to 80 mg. Nothing else changes. Because the shared components are at identical quantities, the two blends can be compared directly.

What is KPV and why is it in this blend?

KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone. It is studied for anti-inflammatory signalling that appears to operate independently of the melanocortin receptors the parent hormone acts through. It adds an inflammation-research arm that the other three components do not cover. Note that most published KPV work uses oral or topical routes rather than injection.

Is there research on the four compounds used together?

No. No pharmacokinetic, safety or efficacy study has examined KPV, GHK-Cu, BPC-157 and TB-500 administered as a fixed blend, and no interaction data exists. The individual components have separate literatures of varying strength, but component evidence does not transfer to a combination. Design protocols from the component literature.

How should the Klow stack be stored?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water or sterile saline, refrigerate at 1–6 °C and protect from light. Because the vial contains four compounds with different stability characteristics, use it within the validated window for the batch rather than extrapolating from any single component.

Is this page medical advice? Can I use Klow for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find Klow specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside Klow.

KPV - companion guide

GHK-Cu - companion guide

BPC-157 - companion guide

TB-500 - companion guide

Glow - companion guide

Scientific sources & further reading

Primary literature and registries for Klow, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on Klow

ClinicalTrials.gov: registered studies on Klow

Klow: Wikipedia (search)

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: KLOW stack, KLOW blend, KPV + GHK-Cu + BPC-157 + TB-500, four-peptide repair blend

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research